Sensient Technologies Corporation Reports Results for the Quarter Ended September 30, 2021
Sensient Technologies reported consolidated revenue of $344.3 million in Q3 2021, a 6.4% increase from Q3 2020. Operating income rose to $47.0 million, up from $41.2 million year-over-year. Diluted EPS increased to 80 cents. The Flavors & Extracts segment saw a 0.7% revenue decline, while Color reported a remarkable 19.6% growth. The company reaffirmed its guidance for a mid-to-high single-digit growth in GAAP EPS for 2021. Adjusted local currency revenue is anticipated to grow at a high single-digit rate.
- Consolidated revenue increased 6.4% year-over-year.
- Operating income rose by 14% compared to the previous year.
- Color segment revenue grew by 19.6% in Q3 2021.
- Adjusted local currency revenue growth expected to be high single-digit for the full year.
- Flavors & Extracts segment revenue declined by 0.7%, primarily due to divestiture.
- Divestiture and related costs decreased net earnings by $1.8 million.
Reported Consolidated Revenue Growth of
Adjusted Consolidated Local Currency Revenue Growth of
Flavors & Extracts Continues its Strong Performance
Color Reports Double Digit Revenue and Profit Growth
The 2021 third quarter reported results include divestiture & other related costs and operational improvement plan costs, which in total decreased third quarter net earnings by
BUSINESS REVIEW | ||||
Reported |
||||
Revenue | Quarter |
Year-to-Date |
||
Flavors & Extracts |
- |
|
||
Color |
|
|
||
|
|
|||
Total Revenue |
|
|
||
Adjusted |
||||
Local Currency (1) |
||||
Revenue | Quarter |
Year-to-Date |
||
Flavors & Extracts |
|
|
||
Color |
|
|
||
|
|
|||
Total Revenue |
|
|
||
(1) Adjusted local currency percentage changes are described in more detail in the "Reconciliation of Non-GAAP Amounts" at the end of this release. |
Corporate & Other reported operating costs of
2021 OUTLOOK
The Company now expects its 2021 adjusted local currency revenue(2) to grow at a high single-digit rate. The Company’s previous 2021 guidance for adjusted local currency revenue(2) was a mid-single-digit growth rate. The Company also now expects its 2021 adjusted local currency EBITDA(2) and adjusted diluted earnings per share(2), on a local currency basis, to grow at a mid-to-high single-digit growth rate. The Company’s previous 2021 adjusted local currency EBITDA(2) and adjusted diluted earnings per share(2) called for a mid-single-digit growth rate.
The Company expects earnings per share reported on a
The Company’s guidance is based upon current trends, current tax law, and the effects of COVID-19 to date. The full impacts of the ongoing COVID-19 pandemic remain uncertain and management will continue to monitor its impacts on our business.
(2) |
See “Reconciliation of Non-GAAP Amounts” at the end of this release for more information. |
USE OF NON-GAAP FINANCIAL MEASURES
The Company’s non-GAAP financial measures eliminate the impact of certain items, which, depending on the measure, include, currency movements, depreciation and amortization, non-cash share-based compensation, divestiture & other related costs, operational improvement plan costs, and the results of the divested operations. These measures are provided to enhance the overall understanding of the Company’s performance when viewed together with the GAAP results. Refer to “Reconciliation of Non-GAAP Amounts” at the end of this release.
CONFERENCE CALL
The Company will host a conference call to discuss its 2021 third quarter financial results at
A replay of the call will be available one hour after the end of the conference call through
This release contains statements that may constitute “forward-looking statements” within the meaning of Federal securities laws including under “2021 Outlook” above. Such forward-looking statements are not guarantees of future performance and involve known and unknown risks, uncertainties and other factors concerning the Company’s operations and business environment. Important factors that could cause actual results to differ materially from those suggested by these forward-looking statements and that could adversely affect the Company’s future financial performance include the following: the impact and uncertainty created by the ongoing COVID-19 pandemic, including, but not limited to, its effects on our employees, facilities, customers, and suppliers, the availability and cost of raw materials and other supplies, the availability of logistics and transportation, governmental regulations and restrictions and general economic conditions; the pace and nature of new product introductions by the Company and the Company’s customers; the Company’s ability to anticipate and respond to changing consumer preferences and changing technologies; the Company’s ability to successfully implement its growth strategies; the outcome of the Company’s various productivity-improvement and cost-reduction efforts, acquisition and divestiture activities, and operational improvement plan; the effectiveness of the Company’s past restructuring activities; changes in costs of raw materials, including energy; industry, regulatory, legal, and economic factors related to the Company’s domestic and international business; the effects of tariffs, trade barriers, and disputes; growth in markets for products in which the Company competes; industry and customer acceptance of price increases; actions by competitors; currency exchange rate fluctuations; and other factors included in “Risk Factors” in the Company's Annual Report on Form 10-K for the year ended
ABOUT
(In thousands, except percentages and per share amounts) | ||||||||||||||||||||||
(Unaudited) | ||||||||||||||||||||||
Consolidated Statements of Earnings |
Three Months Ended |
Nine Months Ended |
||||||||||||||||||||
2021 |
2020 |
% Change |
2021 |
2020 |
% Change |
|||||||||||||||||
Revenue | $ |
344,287 |
|
$ |
323,566 |
|
6.4 |
% |
$ |
1,039,816 |
|
$ |
997,333 |
|
4.3 |
% |
||||||
Cost of products sold |
|
229,216 |
|
|
217,920 |
|
5.2 |
% |
|
697,538 |
|
|
677,580 |
|
2.9 |
% |
||||||
Selling and administrative expenses |
|
68,113 |
|
|
64,491 |
|
5.6 |
% |
|
212,670 |
|
|
201,912 |
|
5.3 |
% |
||||||
Operating income |
|
46,958 |
|
|
41,155 |
|
14.1 |
% |
|
129,608 |
|
|
117,841 |
|
10.0 |
% |
||||||
Interest expense |
|
3,037 |
|
|
3,497 |
|
|
9,792 |
|
|
11,412 |
|
||||||||||
Earnings before income taxes |
|
43,921 |
|
|
37,658 |
|
|
119,816 |
|
|
106,429 |
|
||||||||||
Income taxes |
|
10,009 |
|
|
4,748 |
|
|
28,300 |
|
|
22,126 |
|
||||||||||
Net earnings | $ |
33,912 |
|
$ |
32,910 |
|
3.0 |
% |
$ |
91,516 |
|
$ |
84,303 |
|
8.6 |
% |
||||||
Earnings per share of common stock: | ||||||||||||||||||||||
Basic | $ |
0.81 |
|
$ |
0.78 |
|
$ |
2.17 |
|
$ |
1.99 |
|
||||||||||
Diluted | $ |
0.80 |
|
$ |
0.78 |
|
$ |
2.16 |
|
$ |
1.99 |
|
||||||||||
Average common shares outstanding: | ||||||||||||||||||||||
Basic |
|
42,024 |
|
|
42,307 |
|
|
42,140 |
|
|
42,299 |
|
||||||||||
Diluted |
|
42,206 |
|
|
42,349 |
|
|
42,287 |
|
|
42,326 |
|
||||||||||
Results by Segment |
Three Months Ended |
Nine Months Ended |
||||||||||||||||||||
Revenue |
2021 |
2020 |
% Change |
2021 |
2020 |
% Change |
||||||||||||||||
Flavors & Extracts | $ |
181,667 |
|
$ |
182,866 |
|
(0.7 |
%) |
$ |
561,979 |
|
$ |
552,975 |
|
1.6 |
% |
||||||
Color |
|
139,239 |
|
|
116,414 |
|
19.6 |
% |
|
408,166 |
|
|
381,205 |
|
7.1 |
% |
||||||
|
33,442 |
|
|
30,740 |
|
8.8 |
% |
|
99,599 |
|
|
89,062 |
|
11.8 |
% |
|||||||
Intersegment elimination |
|
(10,061 |
) |
|
(6,454 |
) |
|
(29,928 |
) |
|
(25,909 |
) |
||||||||||
Consolidated | $ |
344,287 |
|
$ |
323,566 |
|
6.4 |
% |
$ |
1,039,816 |
|
$ |
997,333 |
|
4.3 |
% |
||||||
Operating Income | ||||||||||||||||||||||
Flavors & Extracts | $ |
25,164 |
|
$ |
23,844 |
|
5.5 |
% |
$ |
76,718 |
|
$ |
67,467 |
|
13.7 |
% |
||||||
Color |
|
27,253 |
|
|
23,559 |
|
15.7 |
% |
|
79,462 |
|
|
75,486 |
|
5.3 |
% |
||||||
|
6,601 |
|
|
6,123 |
|
7.8 |
% |
|
19,146 |
|
|
16,031 |
|
19.4 |
% |
|||||||
Corporate & Other |
|
(12,060 |
) |
|
(12,371 |
) |
|
(45,718 |
) |
|
(41,143 |
) |
||||||||||
Consolidated | $ |
46,958 |
|
$ |
41,155 |
|
14.1 |
% |
$ |
129,608 |
|
$ |
117,841 |
|
10.0 |
% |
(In thousands) | ||||||
(Unaudited) | ||||||
Consolidated Condensed Balance Sheets |
|
|
||||
2021 |
2020 |
|||||
Cash and cash equivalents | $ |
32,939 |
$ |
24,770 |
||
Trade accounts receivable |
|
263,710 |
|
234,132 |
||
Inventories |
|
392,231 |
|
381,346 |
||
Prepaid expenses and other current assets |
|
50,081 |
|
48,578 |
||
Assets held for sale |
|
- |
|
52,760 |
||
Total Current Assets |
|
738,961 |
|
741,586 |
||
|
437,729 |
|
434,220 |
|||
Property, plant, and equipment (net) |
|
437,789 |
|
445,493 |
||
Other assets |
|
113,937 |
|
119,561 |
||
Total Assets | $ |
1,728,416 |
$ |
1,740,860 |
||
Trade accounts payable | $ |
123,894 |
$ |
107,324 |
||
Short-term borrowings |
|
10,483 |
|
9,247 |
||
Other current liabilities |
|
89,988 |
|
82,045 |
||
Liabilities held for sale |
|
- |
|
17,339 |
||
Total Current Liabilities |
|
224,365 |
|
215,955 |
||
Long-term debt |
|
490,901 |
|
518,004 |
||
Accrued employee and retiree benefits |
|
30,258 |
|
28,941 |
||
Other liabilities |
|
43,500 |
|
43,624 |
||
Shareholders' Equity |
|
939,392 |
|
934,336 |
||
Total Liabilities and Shareholders' Equity | $ |
1,728,416 |
$ |
1,740,860 |
(In thousands, except per share amounts) | |||||||||
(Unaudited) | |||||||||
Consolidated Statements of Cash Flows | |||||||||
Nine Months Ended |
|||||||||
2021 |
2020 |
||||||||
Cash flows from operating activities: | |||||||||
Net earnings | $ |
91,516 |
|
$ |
84,303 |
|
|||
Adjustments to arrive at net cash provided by operating activities: | |||||||||
Depreciation and amortization |
|
38,828 |
|
|
36,831 |
|
|||
Share-based compensation expense |
|
6,431 |
|
|
4,017 |
|
|||
Net loss (gain) on assets |
|
203 |
|
|
(254 |
) |
|||
Loss on divestitures and other charges |
|
13,774 |
|
|
5,821 |
|
|||
Deferred income taxes |
|
3,793 |
|
|
(9,001 |
) |
|||
Changes in operating assets and liabilities: | |||||||||
Trade accounts receivable |
|
(35,290 |
) |
|
(7,962 |
) |
|||
Inventories |
|
(15,898 |
) |
|
17,433 |
|
|||
Prepaid expenses and other assets |
|
(15,016 |
) |
|
(4,726 |
) |
|||
Trade accounts payable and other accrued expenses |
|
24,007 |
|
|
9,018 |
|
|||
Accrued salaries, wages, and withholdings |
|
1,763 |
|
|
7,410 |
|
|||
Income taxes |
|
(1,155 |
) |
|
(3,899 |
) |
|||
Other liabilities |
|
3,192 |
|
|
3,936 |
|
|||
Net cash provided by operating activities |
|
116,148 |
|
|
142,927 |
|
|||
Cash flows from investing activities: | |||||||||
Acquisition of property, plant, and equipment |
|
(37,608 |
) |
|
(34,009 |
) |
|||
Proceeds from sale of assets |
|
201 |
|
|
1,022 |
|
|||
Proceeds from divestiture of businesses |
|
36,790 |
|
|
12,228 |
|
|||
Acquisition of new business |
|
(13,875 |
) |
|
- |
|
|||
Other investing activities |
|
1,348 |
|
|
4,955 |
|
|||
Net cash used in investing activities |
|
(13,144 |
) |
|
(15,804 |
) |
|||
Cash flows from financing activities: | |||||||||
Proceeds from additional borrowings |
|
55,589 |
|
|
33,164 |
|
|||
Debt payments |
|
(67,534 |
) |
|
(101,061 |
) |
|||
Purchase of treasury stock |
|
(31,467 |
) |
|
- |
|
|||
Dividends paid |
|
(49,468 |
) |
|
(49,537 |
) |
|||
Other financing activities |
|
(582 |
) |
|
(415 |
) |
|||
Net cash used in financing activities |
|
(93,462 |
) |
|
(117,849 |
) |
|||
Effect of exchange rate changes on cash and cash equivalents |
|
(1,373 |
) |
|
(3,527 |
) |
|||
Net increase in cash and cash equivalents |
|
8,169 |
|
|
5,747 |
|
|||
Cash and cash equivalents at beginning of period |
|
24,770 |
|
|
21,153 |
|
|||
Cash and cash equivalents at end of period | $ |
32,939 |
|
$ |
26,900 |
|
|||
Supplemental Information | |||||||||
Nine Months Ended |
2021 |
2020 |
|||||||
Dividends paid per share | $ |
1.17 |
|
$ |
1.17 |
|
(In thousands, except percentages and per share amounts) | |||||||||||||
(Unaudited) | |||||||||||||
Reconciliation of Non-GAAP Amounts | |||||||||||||
The Company's results for the three and nine months ended |
Three Months Ended |
Nine Months Ended |
||||||||||||||||||||||
2021 |
2020 |
% Change |
2021 |
2020 |
% Change |
||||||||||||||||||
Revenue (GAAP) | $ |
344,287 |
|
$ |
323,566 |
|
6.4 |
% |
$ |
1,039,816 |
|
$ |
997,333 |
|
4.3 |
% |
|||||||
Revenue of the divested product lines |
|
(1,622 |
) |
|
(23,588 |
) |
|
(29,399 |
) |
|
(88,390 |
) |
|||||||||||
Adjusted revenue | $ |
342,665 |
|
$ |
299,978 |
|
14.2 |
% |
$ |
1,010,417 |
|
$ |
908,943 |
|
11.2 |
% |
|||||||
Operating income (GAAP) | $ |
46,958 |
|
$ |
41,155 |
|
14.1 |
% |
$ |
129,608 |
|
$ |
117,841 |
|
10.0 |
% |
|||||||
Divestiture & other related costs (income) – Cost of products sold |
|
- |
|
|
(148 |
) |
|
28 |
|
|
1,791 |
|
|||||||||||
Divestiture & other related costs – Selling and administrative expenses |
|
241 |
|
|
312 |
|
|
13,473 |
|
|
8,689 |
|
|||||||||||
Operating loss (income) of the divested product lines |
|
70 |
|
|
(2,449 |
) |
|
(2,398 |
) |
|
(4,165 |
) |
|||||||||||
Operational improvement plan - Cost of products sold |
|
- |
|
|
35 |
|
|
- |
|
|
35 |
|
|||||||||||
Operational improvement plan - Selling and administrative expenses (income) |
|
483 |
|
|
2,606 |
|
|
(2,010 |
) |
|
2,606 |
|
|||||||||||
Adjusted operating income | $ |
47,752 |
|
$ |
41,511 |
|
15.0 |
% |
$ |
138,701 |
|
$ |
126,797 |
|
9.4 |
% |
|||||||
Net earnings (GAAP) | $ |
33,912 |
|
$ |
32,910 |
|
3.0 |
% |
$ |
91,516 |
|
$ |
84,303 |
|
8.6 |
% |
|||||||
Divestiture & other related costs, before tax |
|
241 |
|
|
164 |
|
|
13,501 |
|
|
10,480 |
|
|||||||||||
Tax impact of divestiture & other related costs |
|
1,179 |
|
|
(787 |
) |
|
283 |
|
|
(1,212 |
) |
|||||||||||
Net loss (earnings) of the divested product lines, before tax |
|
70 |
|
|
(2,449 |
) |
|
(2,398 |
) |
|
(4,165 |
) |
|||||||||||
Tax impact of the divested product lines |
|
(18 |
) |
|
655 |
|
|
590 |
|
|
1,155 |
|
|||||||||||
Operational improvement plan costs (income), before tax |
|
483 |
|
|
2,641 |
|
|
(2,010 |
) |
|
2,641 |
|
|||||||||||
Tax impact of operational improvement plan |
|
(115 |
) |
|
(656 |
) |
|
44 |
|
|
(656 |
) |
|||||||||||
Adjusted net earnings | $ |
35,752 |
|
$ |
32,478 |
|
10.1 |
% |
$ |
101,526 |
|
$ |
92,546 |
|
9.7 |
% |
|||||||
Diluted earnings per share (GAAP) | $ |
0.80 |
|
$ |
0.78 |
|
2.6 |
% |
$ |
2.16 |
|
$ |
1.99 |
|
8.5 |
% |
|||||||
Divestiture & other related costs (income), net of tax |
|
0.03 |
|
|
(0.01 |
) |
|
0.33 |
|
|
0.22 |
|
|||||||||||
Results of operations of the divested product lines, net of tax |
|
0.00 |
|
|
(0.04 |
) |
|
(0.04 |
) |
|
(0.07 |
) |
|||||||||||
Operational improvement plan costs (income), net of tax |
|
0.01 |
|
|
0.05 |
|
|
(0.05 |
) |
|
0.05 |
|
|||||||||||
Adjusted diluted earnings per share | $ |
0.85 |
|
$ |
0.77 |
|
10.4 |
% |
$ |
2.40 |
|
$ |
2.19 |
|
9.6 |
% |
|||||||
Note: Earnings per share calculations may not foot due to rounding differences. |
(In thousands) | |||||||||||||||||||||||||
(Unaudited) | |||||||||||||||||||||||||
Reconciliation of Non-GAAP Amounts - Continued | |||||||||||||||||||||||||
Results by Segment |
Three Months Ended |
||||||||||||||||||||||||
Adjusted |
Adjusted |
||||||||||||||||||||||||
Revenue |
2021 |
Adjustments (1) |
2021 |
2020 |
Adjustments (1) |
2020 |
|||||||||||||||||||
Flavors & Extracts | $ |
181,667 |
|
$ |
(1,312 |
) |
$ |
180,355 |
|
$ |
182,866 |
|
$ |
(22,978 |
) |
$ |
159,888 |
|
|||||||
Color |
|
139,239 |
|
|
(310 |
) |
|
138,929 |
|
|
116,414 |
|
|
(669 |
) |
|
115,745 |
|
|||||||
|
33,442 |
|
|
- |
|
|
33,442 |
|
|
30,740 |
|
|
(68 |
) |
|
30,672 |
|
||||||||
Intersegment elimination |
|
(10,061 |
) |
|
- |
|
|
(10,061 |
) |
|
(6,454 |
) |
|
127 |
|
|
(6,327 |
) |
|||||||
Consolidated | $ |
344,287 |
|
$ |
(1,622 |
) |
$ |
342,665 |
|
$ |
323,566 |
|
$ |
(23,588 |
) |
$ |
299,978 |
|
|||||||
Operating Income | |||||||||||||||||||||||||
Flavors & Extracts | $ |
25,164 |
|
$ |
66 |
|
$ |
25,230 |
|
$ |
23,844 |
|
$ |
(2,241 |
) |
$ |
21,603 |
|
|||||||
Color |
|
27,253 |
|
|
4 |
|
|
27,257 |
|
|
23,559 |
|
|
(185 |
) |
|
23,374 |
|
|||||||
|
6,601 |
|
|
- |
|
|
6,601 |
|
|
6,123 |
|
|
(23 |
) |
|
6,100 |
|
||||||||
Corporate & Other |
|
(12,060 |
) |
|
724 |
|
|
(11,336 |
) |
|
(12,371 |
) |
|
2,805 |
|
|
(9,566 |
) |
|||||||
Consolidated | $ |
46,958 |
|
$ |
794 |
|
$ |
47,752 |
|
$ |
41,155 |
|
$ |
356 |
|
$ |
41,511 |
|
|||||||
Results by Segment |
Nine Months Ended |
||||||||||||||||||||||||
Adjusted |
Adjusted |
||||||||||||||||||||||||
Revenue |
2021 |
Adjustments (1) |
2021 |
2020 |
Adjustments (1) |
2020 |
|||||||||||||||||||
Flavors & Extracts | $ |
561,979 |
|
$ |
(27,616 |
) |
$ |
534,363 |
|
$ |
552,975 |
|
$ |
(75,165 |
) |
$ |
477,810 |
|
|||||||
Color |
|
408,166 |
|
|
(1,638 |
) |
|
406,528 |
|
|
381,205 |
|
|
(13,242 |
) |
|
367,963 |
|
|||||||
|
99,599 |
|
|
(295 |
) |
|
99,304 |
|
|
89,062 |
|
|
(402 |
) |
|
88,660 |
|
||||||||
Intersegment elimination |
|
(29,928 |
) |
|
150 |
|
|
(29,778 |
) |
|
(25,909 |
) |
|
419 |
|
|
(25,490 |
) |
|||||||
Consolidated | $ |
1,039,816 |
|
$ |
(29,399 |
) |
$ |
1,010,417 |
|
$ |
997,333 |
|
$ |
(88,390 |
) |
$ |
908,943 |
|
|||||||
Operating Income | |||||||||||||||||||||||||
Flavors & Extracts | $ |
76,718 |
|
$ |
(2,859 |
) |
$ |
73,859 |
|
$ |
67,467 |
|
$ |
(5,078 |
) |
$ |
62,389 |
|
|||||||
Color |
|
79,462 |
|
|
548 |
|
|
80,010 |
|
|
75,486 |
|
|
1,029 |
|
|
76,515 |
|
|||||||
|
19,146 |
|
|
(87 |
) |
|
19,059 |
|
|
16,031 |
|
|
(116 |
) |
|
15,915 |
|
||||||||
Corporate & Other |
|
(45,718 |
) |
|
11,491 |
|
|
(34,227 |
) |
|
(41,143 |
) |
|
13,121 |
|
|
(28,022 |
) |
|||||||
Consolidated | $ |
129,608 |
|
$ |
9,093 |
|
$ |
138,701 |
|
$ |
117,841 |
|
$ |
8,956 |
|
$ |
126,797 |
|
|||||||
(1) For Revenue, adjustments consist of revenues of the divested product lines. For Operating Income, adjustments consist of the results of the divested product lines, divestiture & other related costs, and operational improvement plan costs and income. |
(In thousands, except percentages) | |||||||||||||||||||||||
(Unaudited) | |||||||||||||||||||||||
Reconciliation of Non-GAAP Amounts - Continued | |||||||||||||||||||||||
The following tables summarize the percentage change in the 2021 results compared to the 2020 results for the corresponding periods. | |||||||||||||||||||||||
Three Months Ended |
|||||||||||||||||||||||
Revenue | Total |
Foreign
|
Adjustments (2) |
Adjusted
|
|||||||||||||||||||
Flavors & Extracts |
|
(0.7 |
%) |
|
1.1 |
% |
(13.4 |
%) |
|
11.6 |
% |
||||||||||||
Color |
|
19.6 |
% |
|
1.9 |
% |
(0.4 |
%) |
|
18.1 |
% |
||||||||||||
|
8.8 |
% |
|
(0.5 |
%) |
(0.2 |
%) |
|
9.5 |
% |
|||||||||||||
Total Revenue |
|
6.4 |
% |
|
1.2 |
% |
(7.8 |
%) |
|
13.0 |
% |
||||||||||||
Operating Income | |||||||||||||||||||||||
Flavors & Extracts |
|
5.5 |
% |
|
0.6 |
% |
(11.1 |
%) |
|
16.0 |
% |
||||||||||||
Color |
|
15.7 |
% |
|
1.8 |
% |
(0.9 |
%) |
|
14.8 |
% |
||||||||||||
|
7.8 |
% |
|
(2.3 |
%) |
(0.4 |
%) |
|
10.5 |
% |
|||||||||||||
Corporate & Other |
|
(2.5 |
%) |
|
0.0 |
% |
(21.0 |
%) |
|
18.5 |
% |
||||||||||||
Total Operating Income |
|
14.1 |
% |
|
1.1 |
% |
(0.9 |
%) |
|
13.9 |
% |
||||||||||||
Diluted Earnings Per Share |
|
2.6 |
% |
|
0.0 |
% |
(6.5 |
%) |
|
9.1 |
% |
||||||||||||
Adjusted EBITDA |
|
14.2 |
% |
|
1.3 |
% |
N/A |
|
|
12.9 |
% |
||||||||||||
Nine Months Ended |
|||||||||||||||||||||||
Revenue | Total |
Foreign
|
Adjustments (2) |
Adjusted
|
|||||||||||||||||||
Flavors & Extracts |
|
1.6 |
% |
|
2.4 |
% |
(10.7 |
%) |
|
9.9 |
% |
||||||||||||
Color |
|
7.1 |
% |
|
3.2 |
% |
(3.4 |
%) |
|
7.3 |
% |
||||||||||||
|
11.8 |
% |
|
3.6 |
% |
(0.2 |
%) |
|
8.4 |
% |
|||||||||||||
Total Revenue |
|
4.3 |
% |
|
2.8 |
% |
(7.1 |
%) |
|
8.6 |
% |
||||||||||||
Operating Income | |||||||||||||||||||||||
Flavors & Extracts |
|
13.7 |
% |
|
1.9 |
% |
(4.9 |
%) |
|
16.7 |
% |
||||||||||||
Color |
|
5.3 |
% |
|
3.5 |
% |
0.8 |
% |
|
1.0 |
% |
||||||||||||
|
19.4 |
% |
|
(0.7 |
%) |
(0.3 |
%) |
|
20.4 |
% |
|||||||||||||
Corporate & Other |
|
11.1 |
% |
|
0.0 |
% |
(11.0 |
%) |
|
22.1 |
% |
||||||||||||
Total Operating Income |
|
10.0 |
% |
|
3.2 |
% |
0.3 |
% |
|
6.5 |
% |
||||||||||||
Diluted Earnings Per Share |
|
8.5 |
% |
|
3.0 |
% |
(1.3 |
%) |
|
6.8 |
% |
||||||||||||
Adjusted EBITDA |
|
9.7 |
% |
|
2.8 |
% |
N/A |
|
|
6.9 |
% |
||||||||||||
(2) For Revenue, adjustments consist of revenues of the divested product lines. For Operating Income, Diluted Earnings per Share, and Adjusted EBITDA, adjustments consist of the results of the divested product lines, divestiture & other related costs, and operational improvement plan costs and income. | |||||||||||||||||||||||
The following table summarizes the reconciliation between Operating Income (GAAP) and Adjusted EBITDA for the three and nine months ended |
|||||||||||||||||||||||
Three Months Ended |
Nine Months Ended |
||||||||||||||||||||||
2021 |
2020 |
% Change |
2021 |
2020 |
% Change |
||||||||||||||||||
Operating income (GAAP) | $ |
46,958 |
|
$ |
41,155 |
|
14.1 |
% |
$ |
129,608 |
|
$ |
117,841 |
|
10.0 |
% |
|||||||
Depreciation and amortization |
|
13,011 |
|
|
12,309 |
|
|
38,828 |
|
|
36,831 |
|
|||||||||||
Depreciation and amortization, divested product lines |
|
(49 |
) |
|
(49 |
) |
|
(146 |
) |
|
(145 |
) |
|||||||||||
Share-based compensation expense |
|
2,243 |
|
|
1,355 |
|
|
6,431 |
|
|
4,017 |
|
|||||||||||
Divestiture & other related costs, before tax |
|
241 |
|
|
164 |
|
|
13,501 |
|
|
10,480 |
|
|||||||||||
Results of operations of the divested product lines, before tax |
|
70 |
|
|
(2,449 |
) |
|
(2,398 |
) |
|
(4,165 |
) |
|||||||||||
Operational improvement plan costs (income), before tax |
|
483 |
|
|
2,641 |
|
|
(2,010 |
) |
|
2,641 |
|
|||||||||||
Adjusted EBITDA | $ |
62,957 |
|
$ |
55,126 |
|
14.2 |
% |
$ |
183,814 |
|
$ |
167,500 |
|
9.7 |
% |
|||||||
The following table summarizes the reconciliation between Net cash provided by operating activities (GAAP) and Free Cash Flow for the three and nine months ended |
|||||||||||||||||||||||
Three Months Ended |
Nine Months Ended |
||||||||||||||||||||||
2021 |
2020 |
% Change |
2021 |
2020 |
% Change |
||||||||||||||||||
Net cash provided by operating activities (GAAP) | $ |
26,887 |
|
$ |
35,313 |
|
(23.9 |
%) |
$ |
116,148 |
|
$ |
142,927 |
|
(18.7 |
%) |
|||||||
Capital expenditures |
|
(12,058 |
) |
|
(12,592 |
) |
|
(37,608 |
) |
|
(34,009 |
) |
|||||||||||
Free Cash Flow | $ |
14,829 |
|
$ |
22,721 |
|
(34.7 |
%) |
$ |
78,540 |
|
$ |
108,918 |
|
(27.9 |
%) |
|||||||
We have included each of these non-GAAP measures in order to provide additional information regarding our underlying operating results and comparable period-over-period performance. Such information is supplemental to information presented in accordance with GAAP and is not intended to represent a presentation in accordance with GAAP. These non-GAAP measures should not be considered in isolation. Rather, they should be considered together with GAAP measures and the rest of the information included in this release and our |
Category: Earnings
View source version on businesswire.com: https://www.businesswire.com/news/home/20211015005097/en/
(414) 347-3706
Source:
FAQ
What was Sensient Technologies' revenue in Q3 2021?
How much did diluted EPS increase for SXT in Q3 2021?
What is the growth outlook for SXT's adjusted local currency revenue?
What segment reported the highest revenue growth for SXT?